VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HUM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HUMHumana Inc.
$385.70$46.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHUMFinancials

Humana Inc. (HUM) Income Statement

30Y historyFree accessUpdated daily

Revenue scaled from $29.5B in 2024Q2 to $41.2B in 2026Q3, yet the combined ratio crossed 100% in both 2024Q4 and 2025Q4 and net income fell to $162.0M in the latest quarter, indicating thin and unstable underwriting margins.

Income StatementBalance SheetCash FlowRatios

HUM Income Statement

Annual statement

HUM Income Statement

Humana Inc. (HUM) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue154.19B129.66B117.81B106.44B92.92B83.65B77.19B64.93B56.94B53.8B54.41B54.29B48.5B41.31B39.13B36.83B33.87B30.96B29.05B25.29B21.42B14.42B13.1B12.23B11.26B10.19B10.6B10.21B9.87B8.04B6.79B
Revenue Growth %22.02%10.06%10.68%14.55%11.09%8.37%18.88%14.03%5.84%-1.11%0.21%11.94%17.4%5.59%6.23%8.75%9.39%6.58%14.87%18.09%48.54%10.03%7.18%8.57%10.46%-3.79%3.76%3.5%22.77%18.39%44.36%
Medical Costs & Claims134.12B110.81B100.66B88.39B75.69B69.2B61.5B53.74B45.75B43.39B44.9B44.18B38.17B32.56B30.94B28.82B27.09B24.78B23.71B20.27B17.42B0000000000
Medical Cost Ratio %86.99%85.46%85.45%83.05%81.46%82.73%79.67%82.76%80.35%80.65%82.52%81.37%78.69%78.82%79.08%78.26%79.98%80.02%81.61%80.15%81.34%0%0%0%0%0%0%0%0%0%0%
Gross Profit20.06B18.85B17.15B18.05B17.23B14.45B15.69B11.19B11.19B7.08B7.77B7.76B7.97B6.69B6.13B5.67B4.76B4.48B4.17B3.66B3.17B0012.23B11.26B10.19B10.6B10.21B9.87B8.04B6.79B
Gross Margin %13.01%14.54%14.55%16.95%18.54%17.27%20.33%17.24%19.65%13.17%14.28%14.3%16.44%16.19%15.65%15.38%14.06%14.46%14.34%14.48%14.8%0%0%100%100%100%100%100%100%100%100%
Gross Profit Growth %-9.94%-4.98%4.72%19.26%-7.91%40.18%0.02%57.95%-8.79%0.04%-2.6%19.2%9.19%8.12%18.93%6.38%7.51%13.76%15.49%---100%8.57%10.46%-3.79%3.76%3.5%22.77%18.39%44.36%
Operating Expenses18.07B17.4B15.52B14.73B13.67B11.03B11.02B7.72B9.12B7.08B7.77B7.76B7.97B6.69B6.13B5.67B4.76B4.48B4.17B3.66B3.17B02B11.89B11.06B10.01B10.48B10.62B9.66B1.14B1.05B
OpEx / Revenue %11.72%13.42%13.17%13.84%14.71%13.19%14.27%11.89%16.01%13.17%14.28%14.3%16.44%16.19%15.65%15.38%14.06%14.46%14.34%14.48%14.8%0%15.23%97.25%98.19%98.2%98.92%103.96%97.94%14.14%15.42%
Depreciation & Amortization763M824M968M917M845M713M616M575M534M485M465M447M449M426M338M303M263M250.27M220.35M184.81M148.6M128.86M117.79M126.78M120.73M171.02M153.62M126.96M128M108M98M
Combined Ratio %98.71%98.88%98.62%96.88%96.16%95.91%93.94%94.66%96.36%93.82%96.8%95.68%95.13%95.01%94.73%93.64%94.04%94.48%95.95%94.63%96.15%0%15.23%97.25%98.19%98.2%98.92%103.96%97.94%14.14%15.42%
Operating Income1.99B1.45B1.63B3.32B3.56B3.42B4.67B3.47B2.07B3.33B1.74B2.35B2.36B2.06B2.06B2.34B2.02B1.71B1.18B1.36B825.23M461.03M439.02M336.21M203.55M183.08M113.99M-404.84M203.08M6.9B5.74B
Operating Margin %1.29%1.12%1.38%3.12%3.84%4.09%6.06%5.34%3.64%6.18%3.2%4.32%4.87%4.99%5.27%6.36%5.96%5.52%4.05%5.37%3.85%3.2%3.35%2.75%1.81%1.8%1.08%-3.96%2.06%85.86%84.58%
Operating Income Growth %--10.69%-50.99%-6.85%4.24%-26.85%34.7%67.31%-37.64%91.04%-25.82%-0.64%14.6%-0.05%-12.03%16.21%18.12%45.18%-13.4%64.58%79%5.01%30.58%65.18%11.18%60.61%128.16%-299.35%-97.06%20.19%39.34%
EBITDA2.75B2.28B2.6B4.24B4.41B4.13B5.29B4.04B2.61B3.81B2.21B2.79B2.81B2.49B2.4B2.65B2.28B1.96B1.4B1.54B973.82M589.89M556.81M462.99M324.28M354.1M267.61M-277.88M331.08M7.01B5.84B
EBITDA Margin %1.78%1.76%2.2%3.98%4.74%4.94%6.85%6.23%4.58%7.08%4.05%5.15%5.8%6.02%6.13%7.19%6.73%6.32%4.81%6.1%4.55%4.09%4.25%3.79%2.88%3.47%2.53%-2.72%3.36%87.21%86.02%
Interest Expense753M631M660M493M401M326M283M242M218M242M189M186M192M140M105M109M105M105.84M80.29M68.88M63.14M39.31M23.17M17.37M17.25M25.3M28.61M33.39M46.97M20M11M
Non-Operating Income-486M-631M-660M-493M-401M-326M-283M-242M-218M694M-189M84M-192M-140M-151M-109M-267.46M-105.84M-183.39M-68.88M-63.14M00-17.37M-17.25M-25.3M-28.61M-33.39M-46.97M6.88B5.73B
Pretax Income1.72B1.45B1.63B3.32B3.56B3.42B4.67B3.47B2.07B4.02B1.55B2.43B2.17B1.92B1.91B2.23B1.75B1.6B992.85M1.29B762.09M421.71M415.85M336.21M203.55M183.08M113.99M-404.84M203.08M00
Pretax Margin %1.12%1.12%1.38%3.12%3.84%4.09%6.06%5.34%3.64%7.47%2.85%4.48%4.47%4.65%4.88%6.07%5.17%5.17%3.42%5.1%3.56%2.92%3.17%2.75%1.81%1.8%1.08%-3.96%2.06%0%0%
Income Tax424M250M413M836M762M485M1.31B763M391M1.57B938M1.16B1.02B690M689M816M650M562.09M345.69M455.62M274.66M113.23M135.84M112.47M67.18M65.91M23.94M-22.42M74M97M6M
Effective Tax Rate %24.62%17.21%25.38%25.18%21.38%14.19%27.96%21.99%18.85%39.1%60.44%47.51%47.14%35.92%36.05%36.51%37.15%35.09%34.82%35.34%36.04%26.85%32.67%33.45%33%36%21%5.54%36.44%--
Net Income1.25B1.19B1.21B2.49B2.81B2.93B3.37B2.71B1.68B2.45B614M1.28B1.15B1.23B1.22B1.42B1.1B1.04B647.15M833.68M487.42M308.48M280.01M223.74M142.75M117.17M90.05M-382.42M128.96M173M12M
Net Margin %0.81%0.92%1.02%2.34%3.02%3.51%4.36%4.17%2.96%4.55%1.13%2.35%2.36%2.98%3.12%3.85%3.24%3.36%2.23%3.3%2.28%2.14%2.14%1.83%1.27%1.15%0.85%-3.74%1.31%2.15%0.18%
Net Income Growth %-3.56%-1.57%-51.51%-11.3%-4.33%-12.89%24.38%60.84%-31.25%298.7%-51.88%11.25%-6.82%0.74%-13.88%29.12%5.71%60.65%-22.37%71.04%58.01%10.17%25.15%56.73%21.83%30.11%123.55%-396.55%-25.46%1341.67%-93.68%
EPS (Diluted)10.229.849.9820.0022.0822.6725.3120.1012.1616.814.078.447.367.737.478.466.476.153.834.912.901.871.721.380.830.700.54-2.280.771.050.07
EPS Growth %-3.75%-1.4%-50.1%-9.42%-2.6%-10.43%25.92%65.3%-27.66%313.02%-51.78%14.67%-4.79%3.48%-11.7%30.76%5.2%60.57%-22%69.31%55.08%8.72%24.64%66.27%18.57%29.63%123.68%-396.1%-26.67%1400%-93.97%
EPS (Basic)-9.8710.0120.0922.2022.7925.4720.1912.2416.944.118.547.447.827.578.586.556.213.875.002.971.911.751.410.850.710.54-2.280.771.060.07
Diluted Shares Outstanding121.83M120.83M120.87M124.44M127.09M129.4M133.01M134.73M138.4M145.58M150.92M151.14M155.87M159.15M163.46M167.83M169.8M169.07M168.97M169.82M168.08M164.96M162.8M162.13M171.99M167.39M166.76M167.73M167.48M165.84M165.28M

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Thin margin medical cost exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Decelerating Into Recent Quarters

Based on Humana's reported figures, quarterly revenue rose from $29.5B in 2024Q2 to $41.2B in 2026Q3, with year-over-year growth of 26.1% in the latest quarter, though this acceleration reflects the scale of membership and premium base expansion rather than verified pricing gains.

The reported top-line expansion suggests strong Medicare Advantage membership growth and premium rate adjustments, but the data does not isolate how much derives from rate versus enrollment. Investors should monitor whether growth sustains as the benchmark environment normalizes, since high revenue growth paired with thin margins may indicate that volume is being purchased at the expense of underwriting discipline.

Combined Ratio Volatility Erodes Underwriting Cushion

According to reported figures, Humana's combined ratio ranged from 94.9% to 103.2% over the ten quarters shown, crossing 100% in both 2024Q4 and 2025Q4, indicating periods where underwriting losses required offset from other income sources.

The recurring fourth-quarter deterioration suggests seasonal utilization pressure that the company has not consistently contained through pricing or cost management. Because the loss ratio moved between roughly 82.6% and 88.3%, the spread between profit and loss periods is narrow, which may indicate limited tolerance for medical cost trend surprises.

Expense Ratio Scale Offsets Thin Claims Buffer

Based on reported quarterly data, Humana's gross margin of 14.5% and operating margin of 1.1% leave limited room for medical cost inflation, with the gap between loss ratio and combined ratio implying expense ratios near 11% to 15% of premiums.

The operating structure relies on administrative efficiency to convert premium volume into earnings, and the implied expense load appears substantial relative to the margin cushion. Investors should monitor whether CenterWell and value-based care investments reduce this expense load over time or simply add fixed costs.

Fourth-Quarter Losses Define the Earnings Cycle

As reported in financial statements, Humana posted net losses of $693.0M in 2024Q4 and $796.0M in 2025Q4, with both periods coinciding with combined ratios above 103%, suggesting a recurring year-end cost pressure pattern.

The consistency of these losses across two fiscal years points toward structural seasonal utilization rather than isolated events, which may reflect the timing of deductible resets and benefit utilization. This pattern warrants further investigation into whether reserve estimation in the final quarter has contributed to the swings.

Latest Beat Rests on Thin Foundation

Based on Humana's reported figures, the latest quarter's $162.0M net income and 1.33 EPS follow a 17.9% year-over-year EPS decline, and the claimed earnings beat is measured against a negative consensus estimate, limiting the reliability of the surprise magnitude.

Because the net margin of 0.9% is thin, a modest reversal in medical cost trend could erase the quarter's gain, and the raised-guidance narrative appears dependent on cost containment holding through upcoming periods. Investors should treat the improved tone as provisional until several consecutive quarters confirm sustained medical cost ratio improvement.

HUM — Frequently Asked Questions

Quick answers to the most common questions about buying HUM stock.

What was Humana Inc.'s (HUM) revenue in 2025?

For fiscal year 2025, Humana Inc. (HUM) reported total revenue of $129.66B. This represents a 1810.2% increase compared to $6.79B in 1996.

Is Humana Inc. (HUM) profitable?

Humana Inc. (HUM) is profitable, generating $1.19B in net income for the fiscal year ending 2025 with a net profit margin of 0.9%.

What is Humana Inc.'s operating profit margin?

Humana Inc. (HUM) reported an operating income of $1.45B, resulting in an operating profit margin of 1.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Humana Inc.'s gross profit and gross margin?

Humana Inc. (HUM) generated $18.85B in gross profit for the year, representing a gross profit margin of 14.5%. This demonstrates the company's core pricing power and production efficiency.